1 |
Dr Debabrata Barmon |
Estimate the efficacy of vaginal self-sampling for detection of High risk HPV infection in women of North East India |
NCDIR-ICMR |
3 year |
2021-24 |
2 |
Dr. A C Kataki |
Identification of Hereditary Breast and Ovarian Cancer (HBOC) syndrome families with breast cancer and their BRCA1 and BRCA2 gene mutilation profiling in North East Indian population |
-- |
-- |
2020 |
3 |
Dr. A K Das |
To Establish a ready network of clinical trial units across the National Cancer Grid to promote multi-centric collaborative research in the field of drug and device development. |
BIRAC |
3 years |
2020 |
4 |
Dr. A K Das |
Adjuvant Radiotherapy in Early Stage Oral Cancers (AREST) – a prospective randomized control trial (with Tata Memorial Hospital, Mumbai), |
National Cancer Grid |
6 years |
2019-2025l |
5 |
Dr. Manigreeva Krishnatreya |
Creation of Geo-Spatial Cancer Map of Assam using GIS and assess geo-environment cancer risk |
---- |
----- |
April 2019 |
6 |
Dr. R Dikshit |
Multi-centric case control study to identify genetic and life style risk factors of gall bladder cancer, |
National Cancer Grid |
3 years |
2019-2022 |
7 |
Dr. R. Dikshit |
Genome-Wide Association Study to Identify Role of Genetic Susceptibility in Buccal Mucosa Cancer, a multi-centric project, |
ICMR |
3 years |
2019-2022 |
8 |
Dr. K Sridhar |
A Multi-Site study on environmental risk factors for GB cancer, and mediating role on reproductive factors and diet. |
PHFI |
3 years |
2019-2022 |
9 |
Dr. Amal Ch Kataki |
Pattern of Care and Survival Studies in Gall Bladder Cancer. |
ICMR (NCDIR) |
--- |
Oct. 2019 |
10 |
Dr. P S Roy |
A global, multicenter, three arms, open-label randomized study to evaluate the efficacy and safety of Nanosomal Docetaxel Lipid Suspension compared to Taxotere® (Docetaxel Injection Concentrate) in triple-negative breast cancer
patients with locally advanced or metastatic breast cancer after failure to prior chemotherapy |
CSR Project |
1 year |
2019 |
11 |
Dr Amal Ch Kataki |
Development of Automated screening system for cervical cancer using a computerised image analysis of PAP smears and validation through multi centre Deployment. |
Meit Y and DHR |
3 Yrs |
2018- 2020 |
12 |
Dr. J D Sharma |
Project E-Mortality (e-Mor project) |
ICMR (NCDIR) |
------- |
Aug. 2018 |
13 |
Dr. Kunal Oswal |
A pilot study to develop an efficacious oral cancer screening strategy of India, |
TEDT |
30 month |
Dec. 2018 |
14 |
Dr. A K Rai |
Determination of Salivary methylome signatures to develop diagnostic biomarkers for oral cancer in North East India. |
SERB, GOI |
2 years |
2017-2019 |
15 |
Dr. A K Rai |
Determine salivary microbiome signatures in tobacco and betel quid associated oral cancer of North-East region of India. |
DBT, GOI |
3 years |
2017-2020 |
16 |
Dr Debabrata Barmon |
Study of prevalence of High-Risk HPV and precancerous lesion in asymptomatic and symptomatic women of kamrup urban district, Assam North-East India by comprehensive rural community level screening. |
DHR |
3 Yrs |
2017- 2020 |
17 |
Dr. B B Borthakur |
Phase III randomized controlled trial of medroxygesterone acetate |
Tata Memorial Centre, Mumbai |
5 years |
2015-2020 |
18 |
Dr. Amal Ch. Kataki |
Pattern of Care and Survival Studies for Head & Neck, Breast, and Uterine Cervical Cancers funded by ICMR. |
ICMR (NCDIR) |
Cont. |
2006 |
19 |
Dr. Debabrata Barmon |
PBCR Kamrup district funded by NCDIR/ICMR |
NCDIR/ICMR |
Cont. |
- |